Despite a revenue dip, Pfizer boosts EPS guidance and showcases robust oncology growth and strategic FDA approvals.
Despite a dip in revenue and EBITDA, Ashland Inc (ASH) showcases strategic resilience and promising areas of growth amidst ongoing market fluctuations.
Amidst a challenging economic landscape, Conduent Inc (CNDT) leverages strategic sales and tech partnerships to bolster its market position.